April 2022

ACC.22 provides an engaging and interactive forum where attendees can learn about the latest science and innovation from top experts and colleagues, and get the latest practice-changing updates in cardiovascular care.

Look out for the latest cardiovascular research from Carelon Research at ACC.22. Registration is required to view presentations. For more information, go to accscientificsession.acc.org .

Carelon Research presentations

Carelon Research authors are indicated in bold.






Poster Presentation

Saturday, April 2, 2022
8:30 AM

Session 1195 – Pulmonary vascular disease: clinical and population science digital presentations

1195-002 / 2 | Real-world perspective: treatment patterns, healthcare resource utilization, and costs among patients with pulmonary arterial hypertension in the United States

Lia N. Pizzicato1, Vijay R. Nadipelli2Samuel Governor1, Jianbin Mao2Stephan Lanes1, John Butler2Rebecca S. Pepe1, Hemant Phatak2, Karim El-Kersh3

1Carelon Research, Wilmington, DE2Acceleron Pharma Inc., a wholly owned subsidiary of Merck Sharp & Dohme Corp., Cambridge, MA, 3University of Nebraska Medical Center, Omaha, NE

Poster Presentation

Monday, April 4, 2022
9:45 AM – 10:30 AM

Session 2004 – Spotlight on Special Topics: Cardio-oncology 13

2004-129 / 129 – Risk of venous thromboembolism in patients on first line of therapy for advanced non-small cell lung cancer: a comparison of immune checkpoint inhibitors and chemotherapy regimens

Alok A. Khorana1, Lisa Rosenblatt2, Radhika Pisupati2Chi Nguyen3John Barron3Kerrin Gallagher3, Jennell Palaia2, T. Christopher Bond2

1Cleveland Clinic, Cleveland, OH; 2Bristol Myers Squibb, New York, NY; 3Carelon Research, Wilmington, DE

Ready to learn more? Let's connect.